Are we prepared for the end of obesity?
LOS ANGELES, CALIFORNIA - APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images)
Sixty years ago, my biology teacher told me (so it must have been true) that after the war, some Americans were so delighted that the restrictions on food had been lifted that they ate capsules containing a tape worm so that they could eat to their heart’s content without getting fat.
Unlimited access to spectator.com.au and app
The weekly edition on the Spectator Australia app
Spectator podcasts and newsletters
Full access to spectator.co.uk
Unlock this article